Company Overview and News


Add MKGAF
to your dashboard

Headline News

Orexigen (OREX) Q3 Loss Narrower Than Expected, Stock Up

2017-11-14 zacks
Orexigen Therapeutics, Inc (OREX - Free Report) reported net loss of $1.35 per share for the third quarter of 2017, which was narrower than the Zacks Consensus Estimate of a loss of $2.13. The company had reported earnings of $1.12 in the year-ago period mainly due to a non-cash settlement gain of $80.2 million, which was recorded as deferred revenues previously. (163-0)

Orexigen Therapeutics' (OREX) CEO Michael Narachi on Q3 2017 Results - Earnings Call Transcript

2017-11-14 seekingalpha
Welcome to the Q3 2017 Orexigen Therapeutics, Inc. Earnings Conference Call. My name is Allie, and I will be your operator for today's call. [Operator Instructions]. Please note that this conference is being recorded. I will now turn the call over to Jason Keyes, Chief Financial Officer. You may begin. (7-0)

Merck KGaA (MKGAF) Q3 Earnings Decline Y/Y, Revenues Flat

2017-11-10 zacks
Merck KGaA reported third-quarter 2017 earnings of $1.77 per American Depositary Share, 6.4% lower than the year-ago figure of $1.90. (104-0)

Zacks Industry Outlook Highlights: DowDuPont, Albemarle, Monsanto, Westlake Chemical and Kraton

2017-11-10 zacks
Chicago, IL – November 10, 2017 – Today, Zacks Equity Research discusses the Chemicals, including DowDuPont Inc. (DWDP - Free Report) , Albemarle Corporation (ALB - Free Report) , Monsanto Company (MON - Free Report) , Westlake Chemical Corp. (WLK - Free Report) and Kraton Corp. (KRA - Free Report) . (68-0)

Chemical Industry on Solid Footing: Stocks Worth a Look

2017-11-10 zacks
The chemical industry is finding traction again after staying down for a while. The industry’s upturn is expected to continue on sustained momentum across major end-markets. (53-0)

Deals of the day-Mergers and acquisitions

2017-11-09 reuters
Nov 9 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday: (16-0)

Merck KGaA (MKGAF) Q3 2017 Results - Earnings Call Transcript

2017-11-09 seekingalpha
Dear ladies and gentlemen, welcome to the Merck Investor/Analysts Conference Call on Third Quarter Results 2017. As a reminder, all participants will be in a listen-only mode. (57-0)

Why Winnebago Industries (WGO) Stock Might be a Great Pick

2017-11-09 zacks
One stock that might be an intriguing choice for investors right now is Winnebago Industries, Inc. (WGO - Free Report) . This is because this security in the Building Products space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. (3-0)

Merck KGaA (MKGAF) Q3 Earnings Down Y/Y, Sales Flat

2017-11-09 zacks
Merck KGaA is a science and technology company specializing in the fields of healthcare, life science and performance materials. The company's portfolio comprises a wide array of products ranging from innovative pharmaceuticals and biopharmaceuticals to life science tools, specialty chemicals and high-tech materials. (2-0)

Valeant Pharmaceuticals (VRX) in Focus: Stock Moves 5.5% Higher

2017-11-09 zacks
Valeant Pharmaceuticals International, Inc. (VRX - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.06 to $14.94 in the past one-month time frame. (167-1)

Take-Two Interactive Software (TTWO) Catches Eye: Stock Jumps 10.6%

2017-11-09 zacks
Take-Two Interactive Software, Inc. (TTWO - Free Report) was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $102.67–$110.65 in the past one-month time frame, witnessed a sharp increase yesterday. (6-0)

DineEquity (DIN) Q3 Earnings Top, Revenues Miss Estimates

2017-11-09 zacks
DineEquity, Inc. (DIN - Free Report) operates full-service restaurants in the United States and in other countries around the globe. The company owns and operates two restaurant concepts, which includes Applebee’s Neighborhood Grill & Bar (Applebee's) – a bar and grill concept of the casual dining restaurant industry; and International House of Pancakes (IHOP), which primarily caters to the family dining segment. (6-0)

Inogen (INGN) Beats Earnings and Revenue Estimates in Q3

2017-11-08 zacks
Inogen Inc. (INGN - Free Report) reported third-quarter 2017 earnings of 33 cents per share which comfortably beat the Zacks Consensus Estimate of 29 cents and improved from the year-ago figure of 16 cents. (8-0)

5 Top Stocks With Powerful Net Profit Margin

2017-11-08 zacks
The primary purpose of a business is to generate profits that can be reinvested for expansion or utilized to reward shareholders. Net profit margin is an effective tool for the measurement of profit generated by a business. Net Profit Margin = Net profit /Sales * 100. Net profit of a business is the amount that remains in the last line (also known as bottom line) of the income statement after all costs (including taxes) have been deducted from revenues. (7-0)

Myriad Genetics (MYGN) Beats on Q1 Earnings & Revenues

2017-11-08 zacks
Myriad Genetics, Inc. (MYGN - Free Report) reported adjusted earnings per share (EPS) of 26 cents in the first quarter of fiscal 2018, up 13% year over year. Moreover, adjusted EPS beat the Zacks Consensus Estimate by 23.8% and surpassed the company’s guided range of 19-21 cents. (8-0)

CUSIP: 589339100